ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

ClinicalTrials.gov ID: NCT06161584

Public ClinicalTrials.gov record NCT06161584. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06161584
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Apellis Pharmaceuticals, Inc.
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Pegcetacoplan Drug

Drug

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 27, 2023
Primary completion
May 31, 2027
Completion
May 31, 2027
Last update posted
Mar 5, 2026

2023 – 2027

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
California Retina Consultants (01-026) Bakersfield California 93309
Retina-Vitreous Associates Medical Group (01-020) Beverly Hills California 90211
Illinois Retina Associates (01-035) Fullerton California 92835
Retinal Consultants Medical Group Inc (01-008) Modesto California 95356
Retina Consultants San Diego Inc. (01-018) Poway California 92064
California Retina Consultants (01-027) Santa Barbara California 93103
Bay Area Retina Associates (01-005) Walnut Creek California 94598
Colorado Retina Associates, PLLC (01-011) Lakewood Colorado 80228
Retina Specialty Institute (01-019) Pensacola Florida 32503
South East Retina Center, PC (01-030) Augusta Georgia 30909
Georgia Retina (01-032) Marietta Georgia 30060
Illinois Retina Associates (01-037) Oak Park Illinois 60304
The Retina Care Center (01-023) Baltimore Maryland 21209
Cumberland Valley Retina Consultants, P.C. (01-002) Hagerstown Maryland 21740
Mid Atlantic Retina Specialist (01-029) Hagerstown Maryland 21740
Retina Consultants of Minnesota, PLLC (01-025) Edina Minnesota 55435
Mid Atlantic Retina Research (01-014) Cherry Hill New Jersey 08034
Mid Atlantic Retina (01-031) Cherry Hill New Jersey 08906
OCLI Research Department (01-007) Oceanside New York 11572
Long Island Vitreoretinal Consultants (01-013) Westbury New York 11590
Western Carolina Retinal Associates, PA (01-009) Asheville North Carolina 28803
Retina Associates of Cleveland, Inc. (01-017) Cleveland Ohio 44122
Retina Associates of Cleveland, Inc. (01-022) Cleveland Ohio 44130
Retina Associates of Cleveland, Inc. (01-016) Youngstown Ohio 44505
Mid Atlantic Retina (01-001) Bethlehem Pennsylvania 18017
The Retina Care Center (01-034) - Satellite Site York Pennsylvania 17402
Black Hills Regional Eye Institute (01-010) Rapid City South Dakota 57701
Tennessee Retina (01-033) Nashville Tennessee 37203
Integrated Clinical Research (01-024) Abilene Texas 79606
Retina Consultants of Texas (01-004) Bellaire Texas 77401
Texas Retina Associates (01-028) Dallas Texas 75231
Retina Consultants of Texas (01-003) The Woodlands Texas 77384
The Retina Group of Washington (01-021) Fairfax Virginia 22031
Pacific Northwest Retina (01-036) Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06161584, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06161584 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →